Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor

被引:46
作者
Ali, MS [1 ]
Sayeski, PP [1 ]
Bernstein, KE [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M908931199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin II activates the Jak-STAT pathway via the AT(1) receptor. We studied two mutant AT(1) receptors, termed M5 and M6, that contain Y to F substitutions for the tyrosine residues naturally found in the third intracellular loop and the carboxyl terminus. After binding ligand, both the M5 and M6 AT(1) receptors trigger STAT1 tyrosine phosphorylation equivalent to that observed with the wild type receptor, indicating that angiotensin II-mediated phosphorylation of STAT1 is independent of these receptor tyrosine residues. In response to angiotensin II, Jak2 autophosphorylates on tyrosine, and Jak2 and STAT1 physically associate, a process that depends on the SH2 domain of STAT1 in vitro. Evaluation of the wild type, M5, and M6 AT(1) receptors showed that angiotensin II-dependent AT(1) receptor-Jak2-STAT1 complex formation is dependent on catalytically active Jak2, not on the receptor tyrosine residues in the third intracellular loop and carboxyl tail. Immunodepletion of Jak2 virtually eliminated the ligand-dependent binding of STAT1 to the AT(1) receptor. These data indicate that the association of STAT1 with the AT(1) receptor is not strictly bimolecular; it requires Jak2 as both a STAT1 kinase and as a molecular bridge linking STAT1 to the AT(1) receptor.
引用
收藏
页码:15586 / 15593
页数:8
相关论文
共 31 条
  • [1] Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT(1) receptor
    Ali, MS
    Sayeski, PP
    Dirksen, LB
    Hayzer, DJ
    Marrero, MB
    Bernstein, KE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) : 23382 - 23388
  • [2] BHAT GJ, 1994, J BIOL CHEM, V269, P31443
  • [3] ACTIVATION OF THE STAT PATHWAY BY ANGIOTENSIN-II IN T3CHO/AT(1A) CELLS - CROSS-TALK BETWEEN ANGIOTENSIN-II AND INTERLEUKIN-6 NUCLEAR SIGNALING
    BHAT, GJ
    THEKKUMKARA, TJ
    THOMAS, WG
    CONRAD, KM
    BAKER, KM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) : 19059 - 19065
  • [4] CHARLENE DM, 1997, J MOL CARDIOL, V29, P2513
  • [5] Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580
    DaSilva, L
    Rui, H
    Erwin, RA
    Howard, OMZ
    Kirken, RA
    Malabarba, MG
    Hackett, RH
    Larner, AC
    Farrar, WL
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 117 (02) : 131 - 140
  • [6] STAT activation by epidermal growth factor (EGF) and amphiregulin - Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1
    David, M
    Wong, L
    Flavell, R
    Thompson, SA
    Wells, A
    Larner, AC
    Johnson, GR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) : 9185 - 9188
  • [7] DZAU V J, 1987, Journal of Cardiovascular Pharmacology, V10, pS9
  • [8] Activation of Jak2 catalytic activity requires phosphorylation of Y-1007 in the kinase activation loop
    Feng, J
    Witthuhn, BA
    Matsuda, T
    Kohlhuber, F
    Kerr, IM
    Ihle, JN
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) : 2497 - 2501
  • [9] An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT
    Fujitani, Y
    Hibi, M
    Fukada, T
    TakahashiTezuka, M
    Yoshida, H
    Yamaguchi, T
    Sugiyama, K
    Yamanaka, Y
    Nakajima, K
    Hirano, T
    [J]. ONCOGENE, 1997, 14 (07) : 751 - 761
  • [10] VASCULAR SMOOTH-MUSCLE CELL HYPERTROPHY VS HYPERPLASIA - AUTOCRINE TRANSFORMING GROWTH FACTOR-BETA-1 EXPRESSION DETERMINES GROWTH-RESPONSE TO ANGIOTENSIN-II
    GIBBONS, GH
    PRATT, RE
    DZAU, VJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) : 456 - 461